Since VEGF is a well-established driver of tumor angiogenesis and metastasis (61), and TAMs are recognized as key sources of pro-angiogenic factors including VEGF (62, 63), we hypothesized that SRGN may facilitate angiogenesis by augmenting VEGF signaling in the TME. Here, VEGFA is linked to neoplasm.